Literature DB >> 16079791

Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.

James R Ewing1, Stephen L Brown, Mei Lu, Swayamprava Panda, Guangliang Ding, Robert A Knight, Yue Cao, Quan Jiang, Tavarekere N Nagaraja, Jamie L Churchman, Joseph D Fenstermacher.   

Abstract

Vasculature in and around the cerebral tumor exhibits a wide range of permeabilities, from normal capillaries with essentially no blood-brain barrier (BBB) leakage to a tumor vasculature that freely passes even such large molecules as albumin. In measuring BBB permeability by magnetic resonance imaging (MRI), various contrast agents, sampling intervals, and contrast distribution models can be selected, each with its effect on the measurement's outcome. Using Gadomer, a large paramagnetic contrast agent, and MRI measures of T(1) over a 25-min period, BBB permeability was estimated in 15 Fischer rats with day-16 9L cerebral gliomas. Three vascular models were developed: (1) impermeable (normal BBB); (2) moderate influx (leakage without efflux); and (3) fast leakage with bidirectional exchange. For data analysis, these form nested models. Model 1 estimates only vascular plasma volume, v(D), Model 2 (the Patlak graphical approach) v(D) and the influx transfer constant K(i). Model 3 estimates v(D), K(i), and the reverse transfer constant, k(b), through which the extravascular distribution space, v(e), is calculated. For this contrast agent and experimental duration, Model 3 proved the best model, yielding the following central tumor means (+/-s.d.; n = 15): v(D) = 0.07 +/- 0.03 for K(i) = 0.0105 +/- 0.005 min(-1) and v(e) = 0.10 +/- 0.04. Model 2 K(i) estimates were approximately 30% of Model 3, but highly correlated (r = 0.80, P < 0.0003). Sizable inhomogeneity in v(D), K(i), and k(b) appeared within each tumor. We conclude that employing nested models enables accurate assessment of transfer constants among areas where BBB permeability, contrast agent distribution volumes, and signal-to-noise vary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16079791     DOI: 10.1038/sj.jcbfm.9600189

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  56 in total

1.  The concordance of MRI and quantitative autoradiography estimates of the transvascular transfer rate constant of albumin in a rat brain tumor model.

Authors:  Ramesh Paudyal; James R Ewing; Tavarekere N Nagaraja; Hassan Bagher-Ebadian; Robert A Knight; Swayamprava Panda; Mei Lu; Karyn Ledbetter; Joseph D Fenstermacher
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

2.  Modeling of Look-Locker estimates of the magnetic resonance imaging estimate of longitudinal relaxation rate in tissue after contrast administration.

Authors:  Ramesh Paudyal; Hassan Bagher-Ebadian; Tavarekere N Nagaraja; Joseph D Fenstermacher; James R Ewing
Journal:  Magn Reson Med       Date:  2011-05-31       Impact factor: 4.668

3.  MRI of blood-brain barrier permeability in cerebral ischemia.

Authors:  Quan Jiang; James R Ewing; Michael Chopp
Journal:  Transl Stroke Res       Date:  2012-03       Impact factor: 6.829

4.  The expression of P2X₇ receptors in EPCs and their potential role in the targeting of EPCs to brain gliomas.

Authors:  Jingqin Fang; Xiao Chen; Shunan Wang; Tian Xie; Xuesong Du; Heng Liu; Sumei Wang; Xue Li; Jinhua Chen; Bo Zhang; Huaping Liang; Yizeng Yang; Weiguo Zhang
Journal:  Cancer Biol Ther       Date:  2015-04-03       Impact factor: 4.742

5.  Multifunctional Photonics Nanoparticles for Crossing the Blood-Brain Barrier and Effecting Optically Trackable Brain Theranostics.

Authors:  Ajay Singh; Woong Kim; Youngsun Kim; Keunsoo Jeong; Chi Soo Kang; YoungSoo Kim; Joonseok Koh; Supriya D Mahajan; Paras N Prasad; Sehoon Kim
Journal:  Adv Funct Mater       Date:  2016-09-05       Impact factor: 18.808

6.  MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.

Authors:  G Ding; Z Zhang; M Chopp; L Li; L Zhang; Q Li; M Wei; Q Jiang
Journal:  Neuroscience       Date:  2014-04-24       Impact factor: 3.590

7.  Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping.

Authors:  Saeid Taheri; Charles Gasparovic; Nadim Jon Shah; Gary A Rosenberg
Journal:  Magn Reson Med       Date:  2010-12-13       Impact factor: 4.668

8.  Joint arterial input function and tracer kinetic parameter estimation from undersampled dynamic contrast-enhanced MRI using a model consistency constraint.

Authors:  Yi Guo; Sajan Goud Lingala; Yannick Bliesener; R Marc Lebel; Yinghua Zhu; Krishna S Nayak
Journal:  Magn Reson Med       Date:  2017-09-14       Impact factor: 4.668

9.  Effects of tyrosine kinase inhibitors and CXCR4 antagonist on tumor growth and angiogenesis in rat glioma model: MRI and protein analysis study.

Authors:  Meser M Ali; Sanath Kumar; Adarsh Shankar; Nadimpalli R S Varma; A S M Iskander; Branislava Janic; Wilson B Chwang; Rajan Jain; Abbas Babajeni-Feremi; Thaiz F Borin; Hassan Bagher-Ebadian; Stephen L Brown; James R Ewing; Ali S Arbab
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

10.  Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study.

Authors:  Kuo-Chen Wei; Po-Chun Chu; Hay-Yan Jack Wang; Chiung-Yin Huang; Pin-Yuan Chen; Hong-Chieh Tsai; Yu-Jen Lu; Pei-Yun Lee; I-Chou Tseng; Li-Ying Feng; Peng-Wei Hsu; Tzu-Chen Yen; Hao-Li Liu
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.